Tier 2 — strong

[Effect of antioxidants lipin and quercetin on indices of lipid peroxidation and antioxidant system in recipients of renal allotransplants]

R O Zohrab'ian
Klinichna khirurhiia 2010 (7):41

Bibliography

PubMed
PMID 20825091
Funding
Funding was not specified in the indexed record or the disclosure metadata available for this entry.
Competing interests
A competing-interest declaration was not available in the indexed record or the disclosure metadata used for this entry.

Study snapshot

DesignClinical perioperative antioxidant-combination report
ModelHuman intervention research
SampleKidney-transplant recipients; sample size not stated in the indexed English abstract
InterventionIntravenous lipin and quercetin added to standard care
DurationDuring surgery and 3–5 days afterward
EndpointsLipid measurements; Oxidative-stress measures

What the study showed, in plain terms

Published in 2010, this source examined kidney and cancer research. Design: Clinical perioperative antioxidant-combination report. Sample/model: Kidney-transplant recipients; sample size not stated in the indexed English abstract. The exposure or intervention was Intravenous lipin and quercetin added to standard care. Follow-up or treatment period: During surgery and 3–5 days afterward.

The abstract reports changes in lipid-peroxidation and antioxidant measures and faster functional recovery.

Doses, allocation, sample size, and adequate comparative outcomes are not provided in the abstract. Combination and reporting limitations prevent attribution to quercetin.

Continue with Quercetin Data Center

For topic-level interpretation, read Quercetin Side Effects and Safety: A Practical Guide. This is a related guide; the citation panel separately identifies articles that directly cite this paper.

Key findings

  • The abstract reports changes in lipid-peroxidation and antioxidant measures and faster functional recovery.
  • The recorded outcome domains were Lipid measurements; Oxidative-stress measures.
  • The result applies to the tested exposure: Intravenous lipin and quercetin added to standard care; During surgery and 3–5 days afterward.

What this study can and cannot tell us

  • Doses, allocation, sample size, and adequate comparative outcomes are not provided in the abstract. Combination and reporting limitations prevent attribution to quercetin.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Source check: PubMed abstract and indexed metadata; full methods were not independently confirmed for this entry. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 2
Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial
Daniel Shoskes et al. · Transplantation · 2005

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology